NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer’s Patients.
Condition(s):Mild to Moderate Alzheimer’s DiseaseLast Updated:September 12, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Mild to Moderate Alzheimer’s DiseaseLast Updated:September 12, 2019Completed
Condition(s):Alzheimer’s DiseaseLast Updated:May 14, 2015Unknown status
Condition(s):Depressive DisorderLast Updated:March 14, 2023Recruiting
Condition(s):Alzheimer’s DiseaseLast Updated:January 25, 2023Completed
Condition(s):DeliriumLast Updated:April 10, 2015Completed
Condition(s):Methamphetamine Dependence; Substance Abuse; Methamphetamine AbuseLast Updated:July 27, 2012Completed
Condition(s):Alzheimer Disease; CVA (Cerebrovascular Accident)Last Updated:March 5, 2021Completed
Condition(s):Rivastigmine ToxicityLast Updated:March 27, 2014Completed
Condition(s):Alzheimer DiseaseLast Updated:March 20, 2012Completed
Condition(s):Alzheimer’s DiseaseLast Updated:May 4, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.